A nurse is teaching a client who has pernicious anemia to self-administer nasal cyanocobalamin. Which of the following information should the nurse include in the teaching?
Explanation & Rationale
Pernicious anemia is a condition caused by a deficiency of intrinsic factor, preventing the absorption of dietary Vitamin B12 (cyanocobalamin). Because the oral route is ineffective in these clients, B12 must be administered via parenteral or nasal routes to bypass the gastrointestinal tract. This therapy is essential for erythropoiesis and preventing irreversible neurological damage. Rationale: A. Using a nasal decongestant shortly before administering nasal cyanocobalamin is not recommended because it can alter the absorption of the vitamin by constricting the nasal vasculature. The client should be taught to avoid hot foods or liquids immediately before or after administration as well. If the client has a significant upper respiratory infection, they may need to switch to an intramuscular injection temporarily. B. Nasal cyanocobalamin is typically administered once per week in a single nostril for maintenance therapy in clients with pernicious anemia. This schedule ensures a consistent supply of Vitamin B12 to maintain adequate red blood cell production and nerve health. The nurse must emphasize the weekly schedule to ensure the client remains compliant and avoids a return of hematologic symptoms. C. There is no clinical requirement for a client to lie down for 1 hour after using nasal cyanocobalamin. The medication is absorbed through the nasal mucosa quite efficiently while the client is in a normal upright position. Instructing the client to lie down for such an extended period is unnecessary and would place an undue burden on their daily routine without improving drug efficacy. D. Pernicious anemia is a chronic, lifelong condition because the lack of intrinsic factor cannot be cured. Therefore, Vitamin B12 replacement therapy must be continued for the duration of the client's life, not just for 6 months. Stopping the medication will eventually lead to a recurrence of megaloblastic anemia and potentially permanent damage to the spinal cord and peripheral ne